HomeAI · summaries
Storia in 2 fonti
Biogen's monoclonal antibody felzartamab wins first global approval in China
China approves Biogen's CD38 antibody felzartamab for multiple myeloma, its first approval anywhere, months after a $100M TJ Biopharma deal.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
global.chinadaily.com.cn
China grants first global approval for felzartamab
A technician conducts cell culture experiments at a TJ Biopharma research and development center in Shanghai. [Photo provided to China Daily]
- ·
endpoints.news
Biogen's monoclonal antibody felzartamab wins first global approval in China
China approves Biogen's CD38 antibody felzartamab for multiple myeloma, its first approval anywhere, months after a $100M TJ Biopharma deal.